Plasma homocysteine and cognitive decline in older hypertensive subjects

Sunil K Narayan1, Brian K Saxby, Michael J Firbank

  • 1Institute for Ageing and Health, Newcastle University, Campus for Ageing and Vitality, Newcastle upon Tyne, UK.

Insights

Elevated homocysteine levels are linked to cognitive decline in older adults, particularly affecting cognition speed and memory. This association appears independent of B12 and folate levels.

Area of Science:

  • Neurology
  • Gerontology
  • Nutritional Science

Background:

  • Elevated plasma homocysteine is associated with cognitive impairment and dementia.
  • The specific cognitive domains affected and independence from B12/folate remain unclear.
  • This study investigates homocysteine's link to cognitive decline in elderly hypertensive individuals.

Purpose of the Study:

  • To examine the relationship between plasma homocysteine levels and cognitive decline.
  • To determine if homocysteine affects specific cognitive domains.
  • To assess if this relationship is independent of B12 and folate.

Main Methods:

  • 182 hypertensive older adults (mean age 80) without dementia were studied over 3-5 years.
  • Annual cognitive assessments evaluated five cognitive domains.
  • Plasma homocysteine, folate, and B12 levels were measured; multivariate regression analyzed associations.

Main Results:

  • Higher homocysteine independently predicted greater decline in cognition speed and episodic memory.
  • The association with executive function was not significant after accounting for folate.
  • No associations were found for working memory or attention with homocysteine, folate, or B12.

Conclusions:

  • Higher plasma homocysteine is associated with cognitive decline in older hypertensive patients.
  • Cognition speed and episodic memory are particularly vulnerable domains.
  • The role of folate in the homocysteine-executive function relationship warrants further investigation.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...